Temporal Trends in the Outcomes of Percutaneous Coronary Intervention With Zotarolimus Eluting Stents Versus Everolimus Eluting Stents: A Meta‐Analysis of Randomized Controlled Trials

ABSTRACT Introduction Long‐term follow‐up results of various trials comparing Zotarolimus eluting stents (ZES) with Everolimus eluting stents (EES) have been published recently. Additionally, over the last decade, there have been new trials comparing the ZES with various commercially available EES....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cardiology (Mahwah, N.J.) N.J.), 2024-06, Vol.47 (6), p.e24306-n/a
Hauptverfasser: Basit, Jawad, Ahmed, Mushood, Shafiq, Aimen, Zaheer, Zaofashan, Nashwan, Abdulqadir J., Ahmed, Aleena, Hamza, Mohammad, Naseer, Usman, Ali, Shafaqat, Gupta, Neelesh, Sattar, Yasar, Kawsara, Akram, Daggubati, Ramesh, Alraies, M. Chadi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACT Introduction Long‐term follow‐up results of various trials comparing Zotarolimus eluting stents (ZES) with Everolimus eluting stents (EES) have been published recently. Additionally, over the last decade, there have been new trials comparing the ZES with various commercially available EES. We aim to conduct an updated meta‐analysis in light of new evidence from randomized controlled trials (RCTs) to provide comprehensive evidence regarding the temporal trends in the clinical outcomes. Methods A comprehensive literature search was conducted across PubMed, Cochrane, and Embase. RCTs comparing ZES with EES for short (
ISSN:0160-9289
1932-8737
1932-8737
DOI:10.1002/clc.24306